AGP Executive Report

Last update: 9 hours ago

Workplace Safety: Massachusetts reports a relentless assault rate—every 36 minutes a hospital worker faces verbal threats, physical assault, or abuse—fueling calls for urgent legislative protections. Behavioral Health: North Dakota opened registration for its Sept. 14-17 Behavioral Health & Children and Family Services Conference, spotlighting suicide prevention, youth development, and evidence-based care. Diabetes Access: Australia’s PBS will list Tresiba Penfill (insulin degludec) from July 1, expanding affordable basal insulin options for people with type 1 diabetes. Allergy Emergency Care: CSL Seqirus says neffy® adrenaline nasal spray is now PBS-listed from July 1 for eligible Australians at risk of anaphylaxis. Cancer Pipeline: Actinium-225 rosopatamab tetraxetan showed encouraging activity in a phase 2 trial for metastatic castration-resistant prostate cancer after Lu-177-PSMA therapy, with a manageable safety profile. Digital Health Policy: Malaysia’s Basic MHIT plan pilot is set to begin by end of July, using selected insurers and private hospitals to refine rollout. Market & Innovation: Alebund Pharmaceuticals (kidney-focused) listed on HKEx Main Board, while researchers report Arc may help explain how Alzheimer’s tau spreads between neurons.

Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.

AGP Wire

fallback image
3 hours ago

Medical imaging market seen reaching $66.02B by 2035

AGP

fallback image
4 hours ago

Sheila Bonner promoted to general manager at Kavis Pharma

AGP

fallback image
4 hours ago

Faex Health launches AI menstrual tracker with gut health insights

AGP

fallback image
4 hours ago

Stephanie Donovan goes from ad tech executive to wellness CEO

AGP


Perspectify logo Perspectify News

Learn about labels.

Labels
Left-wing Center-left Neutral Public Broadcaster Gov't Institution Center-right Right-wing Pro-Government Gov't Propaganda Indeterminate
filter

Filter

Source Label Filters

All labels are selected. Deselect any labels you want to hide from your feed.

Labels:

Left-wing
Center-left
Neutral
Public Broadcaster
Gov't Institution
Center-right
Right-wing
Pro-Government
Gov't Propaganda
Indeterminate
Package deals in the pharmaceutical industry and Disclosure UK data

Package deals in the pharmaceutical industry and Disclosure UK data

Pharmacist says diabetes sign is 'hiding in plain sight' and starts with one thing

Pharmacist says diabetes sign is 'hiding in plain sight' and starts with one thing

Corporate Supremacist Super PACs Drive $500 Million Midterm Spending Surge

Corporate Supremacist Super PACs Drive $500 Million Midterm Spending Surge

Business News | Climekare Sustainability Private Limited Signs Strategic MoU with European Business and Technology Centre to Accelerate India's Low-Carbon Transition

Business News | Climekare Sustainability Private Limited Signs Strategic MoU with European Business and Technology Centre to Accelerate India's Low-Carbon Transition

As featured in:

@ Journalists!

Join

No journalists yet — this is a new service area. Join today!

Journalists Wanted

fallback image
5 hours ago

Plus Therapeutics Provides Mid-Year Business Update Including Corporate Rebranding

GlobeNewswire, Inc.

fallback image
3 hours ago

Medical Imaging Market to Reach USD 66.02 Billion by 2035 at 4.63% CAGR

EIN Presswire

fallback image
3 hours ago

The Sequoia Project Releases New Guidance To Advance Automated Consent for Health Information Exchange

GlobeNewswire, Inc.

fallback image
3 hours ago

Exigent Technologies Ranked on 2026 MSP 501—Tech Industry’s Most Prestigious List of Global Managed Service Providers

EIN Presswire

fallback image
3 hours ago

SS Innovations Named Outstanding Company Winner at the 2026 Surgical Robotics Industry Awards

GlobeNewswire, Inc.

fallback image
3 hours ago

Arcutis Launches New Virtual Health Platform Supporting Access to Care for Individuals Living with Chronic Inflammatory Skin Diseases, Including Approved ZORYVE® (roflumilast) Indications

GlobeNewswire, Inc.

More press releases

Video Stories

YouTube video thumbnail: Living With ALS: a Former Paramedic’s Story
Play
Living With ALS: a Former Paramedic’s Story
YouTube video thumbnail: Millions of Women With Menopause Barred From Hormone Replacement Therapy Because of Health Risk
Play
Millions of Women With Menopause Barred From Hormone Replacement Therapy Because of Health Risk
Affinity Group Publishing Logo Showcase
Discover Affinity Group Publishing
YouTube video thumbnail: Who Decides if you Sleep Well: you or Your Watch?
Play
Who Decides if you Sleep Well: you or Your Watch?
YouTube video thumbnail: India: How Heatwaves Harm Sleep and Health
Play
India: How Heatwaves Harm Sleep and Health

Video Title

Sign up for:

Health Industry Watch

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

globe

Explore More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Health Industry Watch

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.